Back
ShockWave Medical Quote, Financials, Valuation and Earnings

America's Cash Bubble Set to Burst on December 13, 2023
Watch His Free Video Here
Buy
52
SWAV
ShockWave Medical
Last Price:
179.25
Seasonality Move:
-1.57%
7 Day Trial
ALL ACCESS PASS
$
7

Tiny Lithium Stock Gets $90M Boost in Global EV Battery Race
Learn more here.ShockWave Medical Price Quote
$179.25
-2.95 (-1.62%)
(Updated: December 4, 2023 at 12:20 PM ET)
ShockWave Medical Key Stats
Buy
52
ShockWave Medical (SWAV)
is a Buy
Day range:
$171.67 - $183.21
52-week range:
$157.00 - $315.95
Dividend yield:
0%
P/E ratio:
31.96
P/S ratio:
10.35
P/B ratio:
11.18%
Volume:
712.7K
Avg. volume:
723K
1-year change:
-27.83%
Market cap:
$6.7B
Revenue:
$489.7M
EPS:
$6.42
How Much Does ShockWave Medical Make?
-
How Much Are ShockWave Medical's Sales Annually?
SWAV Revenues are $489.7M -
How Much Profit Does ShockWave Medical's Make A Year?
SWAV net income is $216M
Is ShockWave Medical Growing As A Company?
-
What Is ShockWave Medical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.42% -
What Is ShockWave Medical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ShockWave Medical Stock Price Performance
-
Did ShockWave Medical Stock Go Up Last Month?
ShockWave Medical share price went down by -14.68% last month -
Did SWAV's Share Price Rise Over The Last Year?
SWAV share price fell by -27.83% over the past 1 year
What Is ShockWave Medical 52-Week High & Low?
-
What Is ShockWave Medical’s 52-Week High Share Price?
ShockWave Medical has traded as high as $315.95 over the past 52 weeks -
What Is ShockWave Medical’s 52-Week Low Share Price?
ShockWave Medical has traded as low as $157.00 over the past 52 weeks
ShockWave Medical Price To Free Cash Flow
-
Is ShockWave Medical Stock Overvalued?
ShockWave Medical is trading at a price to free cash flow ratio of 48.49 -
Is ShockWave Medical Stock Undervalued?
ShockWave Medical EV to Free Cash Flow ratio is 45.63 -
What Is ShockWave Medical’s Price Earnings Growth Ratio?
SWAV PEG ratio is 0.16 -
Is ShockWave Medical Trading At A Premium To Earnings?
ShockWave Medical EV to EBIT ratio is 38.81
Is It Risky To Buy ShockWave Medical?
-
How Much Debt Does ShockWave Medical Have?
Total long term debt quarterly is $730.9M -
How Much Cash Does ShockWave Medical Have?
Cash and short term investments quarterly total is $917.3M -
What Is ShockWave Medical’s Book Value Per Share?
Book value per share is 16.30
Is ShockWave Medical Cash Flow Positive?
-
What Is SWAV Cash Flow From Operations?
Cash flow from operations (TTM) is $176.8M -
What Is ShockWave Medical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $610.2M -
What Is ShockWave Medical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$418.7M
ShockWave Medical Return On Invested Capital
-
Is Management Doing A Good Job?
SWAV return on invested capital is 34.31% -
What Is ShockWave Medical Return On Assets?
ROA measures how assets are converting to revenues and is 29.27% -
What Is SWAV Return On Equity?
ROE is a measure of profitability and is 45.91%
ShockWave Medical Earnings Date & Stock Price
-
What Is ShockWave Medical's Stock Price Today?
A single share of SWAV can be purchased today for 182.20 -
What Is ShockWave Medical’s Stock Symbol?
ShockWave Medical trades on the nasdaq under the ticker symbol: SWAV -
When Is ShockWave Medical’s Next Earnings Date?
The next quarterly earnings date for ShockWave Medical is scheduled on February 16, 2024 -
When Is SWAV's next ex-dividend date?
ShockWave Medical's next ex-dividend date is December 4, 2023 -
How To Buy ShockWave Medical Stock?
You can buy ShockWave Medical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ShockWave Medical Competitors
-
Who Are ShockWave Medical's Competitors?
Below is a list of companies who compete with ShockWave Medical or are related in some way:
ShockWave Medical Dividend Yield
Data Unavailable
ShockWave Medical Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 23.54% |
Revenue: | 41.64% | 0.71% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 1 |
Price Target: | 239.91 |
Upside from Last Price: | 31.67% |